Grant: Operating Grant - Priority Announcement: Breast Cancer
University of Ottawa
$100,000.00
MicroRNA signature in chemoprevention of mammary carcinoma by probiotics through control of cancer stem cells.
FY 2013-14
Summary
Diet has been identified as a key priority in achieving dramatic improvements in cancer control and is at the core of the WHO's worldwide cancer strategy. Moreover, substantial scientific evidence is mounting proclaiming that naturally occurring dietary compounds are efficient in breast cancer chemoprevention and as adjunct therapy. In fact, the ongoing battle against breast cancer is quickly advancing by recent experiments pointing to key molecular mechanisms that can be exploited in prevention and relapse. In particular, regulatory biomolecules (microRNA) might, through epigenetic alteration, promote or suppress tumorigenesis. In addition, cellular transformation in the mammary gland is sustained by a network involving inflammation-associated signals. This network eventually produces a subpopulation of cells with increased self-renewal and tumorigenic potential, the Cancer Stem Cells (CSC) known as the -cancer roots-. Clinically, CSCs are thought to be responsible for therapy resistance and tumor recurrence. MicroRNAs have emerged as critical regulators of CSCs in tumor development and metastasis. In collaboration with the International Agency for Research on Cancer, we have identified a nutraceutical approach that targets CSC-specific pathways by changing microRNA signature and effectively modulating CSC functions. We postulate that such dietary components indirectly influence tumour-suppressive or oncogenic microRNAs leading to cancer-related CSCs proliferation control.
We aim to validate the effect of the distinct microRNAs signature induced by a probiotic-like product in tumor progression, and metastasis in animal model, and study the chemo-sensitization effect on chemotherapeutic drug Dox.
The study will provide novel evidence showing that dietary components modulate anti-inflammatory deactivation of CSCs. It will also improve the design of dietary supplements with individually-tailored anti-inflammatory properties to prevent and control relapse in cancer.
Department
Program
Operating Grant - Priority Announcement: Breast Cancer
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
309761
Name
Matar Chantal
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Nutrition, Metabolism and Diabetes
Theme2
Biomedical
Prcname2
Nutrition, Food & Health
Projecttitle
MicroRNA signature in chemoprevention of mammary carcinoma by probiotics through control of cancer stem cells.
Programtype2
Operating Grants
Orgnameinp2
University of Ottawa
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
Operating Grant - Priority Announcement: Breast Cancer
Keyworddelim
Anti-Inflammatory Mechanisms; Breast Cancer; Cancerous Stem Cells; Chemoprevention; Epigenetic Modulation; Il-6 Signalling Pathways; Microrna; Mucosal Tumoural Immunity; Nutrition/Immunosurveillance; Probiotics/Bioactive
Abstract
Diet has been identified as a key priority in achieving dramatic improvements in cancer control and is at the core of the WHO's worldwide cancer strategy. Moreover, substantial scientific evidence is mounting proclaiming that naturally occurring dietary compounds are efficient in breast cancer chemoprevention and as adjunct therapy. In fact, the ongoing battle against breast cancer is quickly advancing by recent experiments pointing to key molecular mechanisms that can be exploited in prevention and relapse. In particular, regulatory biomolecules (microRNA) might, through epigenetic alteration, promote or suppress tumorigenesis. In addition, cellular transformation in the mammary gland is sustained by a network involving inflammation-associated signals. This network eventually produces a subpopulation of cells with increased self-renewal and tumorigenic potential, the Cancer Stem Cells (CSC) known as the -cancer roots-. Clinically, CSCs are thought to be responsible for therapy resistance and tumor recurrence. MicroRNAs have emerged as critical regulators of CSCs in tumor development and metastasis. In collaboration with the International Agency for Research on Cancer, we have identified a nutraceutical approach that targets CSC-specific pathways by changing microRNA signature and effectively modulating CSC functions. We postulate that such dietary components indirectly influence tumour-suppressive or oncogenic microRNAs leading to cancer-related CSCs proliferation control.
We aim to validate the effect of the distinct microRNAs signature induced by a probiotic-like product in tumor progression, and metastasis in animal model, and study the chemo-sensitization effect on chemotherapeutic drug Dox.
The study will provide novel evidence showing that dietary components modulate anti-inflammatory deactivation of CSCs. It will also improve the design of dietary supplements with individually-tailored anti-inflammatory properties to prevent and control relapse in cancer.
Competitiondate
201403
Approvedterm2
1 yr 0 mth
Pinamesdelim
Matar, Chantal
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $100,000~ $0~